LCX CHLAMYDIA TRACHOMATIS ASSAY— 510(k) K934622

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K934622 for LCX CHLAMYDIA TRACHOMATIS ASSAY, Substantially Equivalent on 1995-12-08. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code MKZ
Advisory panel: Microbiology
Date received: 1993-09-27
Decision date: 1995-12-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.